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Cancer cells can undergo stress-induced premature senescence, which is considered to be a desirable outcome
of anticancer treatment. However, the escape from senescence and cancer cell repopulation give rise to some
doubts concerning the effectiveness of the senescence-induced anticancer therapy. Similarly, it is postulated that
polyploidization of cancer cells is connected with disease relapse. We postulate that cancer cell polyploidization
associated with senescence is the culprit of atypical cell divisions leading to cancer cell regrowth. Accordingly, we
aimed to dissociate between these two phenomena. We induced senescence in HCT 116 cells by pulse treatment
with doxorubicin and observed transiently increased ploidy, abnormal nuclear morphology, and various
distributions of some proteins (e.g., p21, Ki-67, SA-β-galactosidase) in the subnuclei. Doxorubicin-treated HCT
116 cells displayed an increased production of reactive oxygen species (ROS) possibly caused by an increased
amount of mitochondria, which are characterized by low membrane potential. A decrease in the level of ROS by
Trolox partially protected the cells from polyploidization but not from senescence. Interestingly, a decreased level
of ROS prevented the cells from escaping senescence. We also show that MCF7 cells senesce, but this is not
accompanied by the increase of ploidy upon doxorubicin treatment. Moreover, they were stably growth arrested,
thus proving that polyploidy but not senescence per se enables to regain the ability to proliferate. Our preliminary
results indicate that the different propensity of the HCT 116 and MCF7 cells to increase ploidy upon cell
senescence could be caused by a different level of the mTOR and/or Pim-1 kinases.
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Cell senescence is associated with irreversible growth arrest. Primary
cells undergo senescence due to telomere erosion, which is known as
replicative senescence [1], or due to stress or oncogenes, resulting in
stress-induced premature senescence (SIPS), which is generally telomere
erosion independent [2]. SIPS occurs in culture much faster than
replicative senescence. Senescent cells despite being metabolically active
have a changed metabolism in comparison with young cells. They
secrete many factors, including proinflammatory ones, which give rise
to the so-called senescence-associated secretory phenotype. Many other
features are common for both replicative senescence and SIPS. The
most frequently revealed ones are cell cycle arrest in the G1 or G2 phase
of the cell cycle, increased size and granularity, activation of the DNA
damage response, and increased activity of the so-called senescence-as-
sociated β-galactosidase (SA-β-Gal) [3,4].
Cancer cells avoid senescence and become immortal. However,
recently, a plethora of reports documented that SIPS could beinduced in cancer cells [5,6]. As a matter of fact, cellular senescence is
considered to be an outcome of radio/chemotherapy. However, there
is a growing body of evidence documenting that senescence of cancer
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cell repopulation observed in patients subjected to radio/chemotherapy
[6]. We postulate that cancer cells’ escape from senescence is strictly
connected with cell polyploidization. Polyploidy is the result of
endoreplication, which is endocycling and endomitosis. Endocycling
cells pass DNA synthesis without mitosis. On the contrary, cells
undergoing endomitosis execute an abortive mitosis that does not result
in cell division, followed by subsequent reentering into the S phase.
Both types of endoreplication can occur in cancer cells [7]. Recently, it
was proposed that tumor cells containing an elevated genomic content
are key players in the evolution of cancer [8].
Regrettably, in some reports showing cells escaping senescence, the
issue of polyploidy was not addressed [9]. In other experiments which
focused on polyploidy formation leading to cell divisions, cell
senescence was not analyzed [10,11]. To our knowledge, there are
only a few convincing studies showing the crucial role of polyploidy in
cancer cell escape from senescence [12–17]. We also showed that
polyploid cells en route to senescence were able to divide, giving rise to
progeny having a different set of chromosomes than mother cells [18].
We asked the question whether reactive oxygen species (ROS)
production can play a role in polyploidization/senescence of cancer
cells. It was shown by others that the antioxidant N-acetyl-L-cysteine
selectively eliminated polyploidy of prostate cancer cells, however, in
these experiments, cell senescence was not considered [19]. In this
study, we were able to show that an antioxidant Trolox can reverse, at
least partially, polyploidy formation and inhibit clonogenicity but not
senescence of doxorubicin-treated HCT 116 cells.
Doxorubicin (dox) is both a DNA damage and ROS-producing
agent [20] as well as a potent antineoplastic drug used in the treatment
of a variety of cancers [21]. DNA damage, including that evoked by
ROS, is considered to be the main culprit of cell senescence [22], and it
is a common effect of cancer cell radio/chemotherapy [23].
Materials and Methods
Cell Lines
The human colon HCT 116 cancer cell line was kindly provided
by Dr. Bert Vogelstein (Johns Hopkins University, Baltimore, MD).
The MCF7 cell line was obtained from ATCC. Authentication of
both cell lines was performed this year by Cell Line Authentication
IdentiCell STR using STR profiling.
Cells were grown under standard conditions (37°C, 5% CO2) in
McCoy’s (HCT 116) or Dulbecco’s modified Eagle’s medium
(MCF7) medium.
Senescence-Associated β-Galactosidase
SA-β-Gal was detected according to Dimri et al. [24] or by flow
cytometry as previously described [18].
Cell Morphology Visualized by Hematoxylin Staining
Cells were fixed for 15 minutes in 96% ethanol at RT then washed
with water and stained with 0.4% hematoxylin for 3 minutes.
Scanning Electron Microscopy
Samples were prepared according to Perletti et al. [25]. All
specimens were observed under a microscope (Zeiss LEO 1430VP).
F-Actin Staining
Cells were fixed in 4% paraformaldehyde for 15 minutes on ice,
washed in PBS, permeabilized with 0.1% Triton X-100 in PBS for 45minutes, and incubated for 30 minutes with TRITC-labeled
phalloidin diluted 1:1000 in PBS. DNA was stained with DAPI
(1 μg/ml in PBS) for 15 minutes, washed again with PBS, and
mounted with the mounting medium.
Immunocytochemistry
Cells grown on coverslips were fixed in ice-cold methanol for lamin
A/C, p53 and p21 staining or in 4% paraformaldehyde (Sigma
Aldrich, Poznan, Poland) at 4°C for 15 minutes for Aurora B and
Ki-67 staining (Abcam, Cambridge, UK) or in ice-cold 70% ethanol
for p-ATM (Ser1981) staining. Afterwards, cells were incubated on
slides with the appropriate antibody, namely, anti-lamin A/C,
anti-p53, and anti-p21(1:100) (Santa Cruz Biotechnology, Inc.,
Dallas, TX) anti-Aurora B (Becton Dickinson, Diag-med, Warsaw,
Poland), anti-Ki-67 (1:200) (Abcam, Cambridge, UK), and anti-
p-ATM (Ser1981) (1:900) (Millipore, Merck, Warsaw, Poland).
Next, secondary Alexa 488– or Alexa Fluor 555–conjugated IgG
antibody (1:1000) was used (Life Technology, Warsaw, Poland). To
visualize the nuclei, DNA was stained using either DAPI (1 μg/ml in
PBS) or DRAQ 5 (10 μM in PBS) (Life Technology, Warsaw,
Poland). The specimens were analyzed using a fluorescent Nikon
Eclipse 50i microscope with an EvolutionVF camera (MediaCyber-
netics) and the ImagePro Plus software or using a confocal microscope
(described in the next section).
Alternatively, for Ki-67 visualization, the biotin-avidin detection
system (Vectastain ABC Kit) was used as described previously [18].
The specimens were analyzed using Nikon Eclipse 50i microscope
with an EvolutionVF camera (MediaCybernetics) and the ImagePro
Plus software.
In the case of immunocytochemistry combined with SA-β-Gal
staining, cells were firstly stained according to the foregoing protocol
(detection of SA-β-Gal), washed twice with PBS, and stained as
described above (without the fixation step).
Confocal Imaging
Specimens were visualized with confocal laser scanning microscope
Leica TCS SP8 using a 63×/1.4 oil immersion lens. Fluorescence was
excited using the 405-nm line from a pulsed laser (for Hoechst/DAPI)
and white light laser for other fluorochromes. Emitted light was
captured using a hybrid Leica detector. Confocal z section stacks were
collected at 0.39-μm spacing through the depth of the specimen. The
final images represent a maximum projection along the z axis.
ROS Measurement
Live cells were incubated with DCF-DA (20 μM in PBS) (Life
Technologies,Warsaw, Poland) for 20 minutes in 37°C and then
trypsinized and measured using the flow cytometry; 30,000 events
were collected per sample.
Mitochondrial Mass Measurement
Live cells were incubated with MitoTracker Green FM (200 nM)
(Life Technology, Warsaw, Poland) for 15 minutes at 37°C in a cell
incubator, washed with PBS, and immediately measured using the
flow cytometer. Results are presented as % of control mean
fluorescence in FL1 channel.
Alternatively, cells on coverslips were incubated with MitoTracker
Green FM, fixed in 4% paraformaldehyde mounted with mounting
medium, and analyzed using a fluorescent Nikon Eclipse 50i
microscope, CCD Evolutions VF camera (MediaCybernetics), and
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APO 63×/1.40-0.60 objective.
Mitochondrial Potential Measurement
Trypsynized cells were preincubated in standard medium for
25 minutes at 37°C and then incubated for 20 minutes with JC-9
(1 μg/ml) (Life Technology, Warsaw, Poland). Next, cells were
washed with PBS and analyzed using the flow cytometer. Cells
incubated with 1 μM FCCP (carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone) were used as a negative control.
DNA Content Analysis
For DNA analysis, cells were trypsinized, fixed in 70% ethanol,
and stained with PI solution (3.8 mM sodium citrate, 50 mg/ml of
RNAse A, 500 mg/ml of PI, in PBS). DNA content was determined
using flow cytometry.
Western Blotting
Whole cell protein extracts were prepared according to the Laemmli
method [26]. Equal amounts of protein were separated electrophoret-
ically in 8%, 12%, or 15% SDS-polyacrylamide gels and afterwards
transferred to nitrocellulose membranes. Membranes were probed with
antibodies specific for p53 (DO-1, 1:500 in TBS with 5% milk), p21
(C-19, 1:500 in TBS/5% milk) (Santa Cruz Biotechnology, Inc.,
Dallas, TX), p-p53 (Ser15) (1:500 in TBS/5% BSA), PARP-1 (1:1000
in TBS/5% milk) (Becton Dickinson, Diag-med, Warsaw, Poland),
β-catenin (1:2000 in TBS/5% BSA), p-p70S6K (Thr 389) (1:1000 in
TBS/5% BSA), p70S6K (1:1000 in TBS/5% BSA), Pim-1(1:1000 in
TBS/5% BSA) (Cell Signaling, Lab-JOT Ltd., Warsaw, Poland), and
β-actin or GAPDH (1:30,000 in TBS/5% BSA) (Sigma Aldrich,
Poznan, Poland) as a loading control. Proteins were detected using an
appropriate secondary HRP-conjugated antibody (1:10,000 in TBS/
5%milk) and ECL (GEHealthcare, Buckinghamshire, UK) reagents as
recommended by the manufacturer.
Senescence-Associated Secretory Phenotype
Concentrations of the secreted proteins in the culture media were
measured using a colorimetric enzyme-linked immunosorbent assay
according to the protocol provided by the manufacturer (R&D,
Biokom, Warsaw, Poland). The levels of cytokines (IL-8, VEGF)
were determined with the use of standard curves, and the results were
normalized to the total cell number.
Clonogenicity Assays
Cells were treated with dox for 24 hours and then cultured in a
drug-free medium for the indicated time. Next, the cells were replated
into 6-well plates at a density of 300 cells per well and cultured for
additional 14 days. The colonies were fixed with methanol and
stained with 4% methylene blue.
Flow Cytometry
All samples were analyzed using a FACS Calibur flow cytometer
(Becton Dickinson, Warsaw, Poland) with CellQuest Software;
10,000 events were counted for each sample.
Results
Senescence Hallmarks of Doxorubicin-Treated HCT 116 Cells
Previously, we have shown that the HCT 116 cells treated with
100 nM dox for 1 day and then cultured in a drug-free medium forseveral days (1 + n) underwent senescence and became SA-β-Gal
positive [18]. Now, we show their extended characteristic (Figure 1).
We proved the formation of active ATM (p-ATM) foci (Figure 1B)
and an increased level of the active form of p53 (phosphorylated on
Ser 15, p-p53) (Figure 1C). ATM is a key enzyme in the DNA
damage response signaling pathway which is upstream of p53/p21
[27]. Thus, we proved that the DNA damage response is activated
in HCT 116 cells undergoing senescence. We only analyzed
adherent cells which were not dying ones as PARP-1 cleavage
could not be observed in these cells (Figure 1C). One of the
important hallmarks of senescent cells is their ability to secrete a
number of factors [28]. Accordingly, we observed an increased
amount of IL-8 and VEGF in the medium of dox-treated cells
(Figure 1D). Typical features of senescent cells are their increased
size and granularity which were visualized by scanning electron
microscopy and flow cytometry (Supp. 1, A and B). Hematoxylin
staining revealed many perinuclear vacuoles. Some of them seemed
to be connected with the nuclei (Supp. 1C).
Nuclear Morphology and Nuclear Protein Distribution in
Doxorubicin-Treated HCT116 Cells
Dox-treated cells underwent intensive polyploidization. As
revealed by the measurement of DNA content using flow cytometry,
the subpopulation of cells having N4C DNA accounted for 50% of
the entire population on days 1 + 4 and 1 + 5 [18]. DNA content
analysis performed after a longer period of time revealed that the cells
underwent subsequent depolyploidization (Figure 1E). Polyploidiza-
tion and depoliploidization can be connected with the life cycle of
cancer, and a different distribution of certain proteins in the subnuclei
of the same polyploid cell has been shown [29,30]. Therefore, we
were interested in how the nuclear morphology and protein
expression connected with cell senescence (p21, SA-β-Gal) look like
in polyploid cells induced to senesce.
Indeed, dox-treated cells seem to have a disorganized structure of
the nuclear lamina as it is visible with lamin A/C staining (Figure 2A).
As can be seen, in perinuclear vesicles, DNA is less stained, probably
due to highly decondensed chromatin; however, nuclear proteins
such as Aurora B, p53, and p21 are all localized in both the nuclei
(colocalized with DNA) and perinuclear vesicles.
Figure 2, A-D shows nuclei of mononuclear cells; however, we
have also observed many multinucleated cells. Interestingly, when we
stained cells for p21, it appeared that, inside the same cell, both
p21-positive and p21-negative micronuclei could be detected
(Figure 2E).
Senescent cells are arrested in the G1 or G2 phase of the cell cycle.
Ki-67 is frequently used as a negative marker of senescent,
nonproliferating cells despite the fact that it was only shown that
cells, which are in the G0 phase and are truly out of the cell cycle, are
deprived of Ki-67 expression [31]. Thus, we double stained cells for
Ki-67 and SA-β-Gal and observed cells under confocal microscope.
The majority of dox-treated HCT 116 cells were Ki-67 positive (not
shown). Moreover, we observed some cells which were double
positive for Ki-67 and SA-β-Gal (Figure 3A), proving that they are
not out of the cell cycle. However, we also observed cells which were
negative for Ki-67 and positive for SA-β-Gal, thus implying that at
least some senescent cells can escape the cell cycle. This issue needs
further investigation.
We also showed that some cells were double stained for Ki-67 and
p21 (Figure 3B).
Figure 1.Markers of senescence in dox-treated HCT 116 cells. (A) SA-β-Gal–positive cells. Cells were untreated or dox treated for 1 + 7
days. Magnification is 200×. (B) Immunochemistry of p-ATM foci. Untreated cells and cells treated for 1 + 2 days are shown. Anti–p-ATM
staining is shown in green; nuclei were visualized in red. The bar represents 30 μm. (C) Western blotting analysis of p-p53, p21, and
PARP-1. β-Actin was used as a loading control. (D) The level of IL-8 and VEGF in the medium of dox-treated cells. Cells were treated as
indicated, and the secretome was measured in five independent experiments. (E) DNA content measured by flow cytometry. Untreated
(day 0) and dox-treated cells are shown as indicated. Statistical significance between untreated and dox-treated cells was estimated using
the Student’s t test. *P b .05, ** P b .01.
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nuclei and different distribution of nuclear proteins inside the same
cell, which could suggest different fate of the cells which arise after
depolyploidization.
ROS Production in Doxorubicin-Treated HCT 116 Cells
Doxorubicin induced both DNA damage and ROS production.
Subsequently, we analyzed the morphology and function of
mitochondria, which could be the culprit of ROS production.
Figure 4(A,B) shows some mitochondrial parameters in HCT 116
cells treated with dox. We used MitoTracker Green FM which
preferentially accumulates in mitochondria, becomes fluorescent in
their lipid environment, and thus gives an estimate of the
mitochondrial mass in cells. We observed green fluorescence all
over the cytoplasm; however, we found a dramatic increase in
perinuclear MitoTracker Green fluorescence in giant cells
(Figure 4A). This immunofluorescence data were confirmed using
flow cytometry, showing again an increase in MitoTracker Greenlabeling in dox-treated cells already on day 1 that reached almost
300% on day 1 + 5 (Figure 4B, left panel). The increase in
mitochondrial mass may result from the induction of a mitochondrial
biogenesis program.
We used the cationic dye JC-9, which localizes to normal
mitochondrial membranes in the form of red aggregates and turns
into a green monomer upon membrane depolarization. Moreover,
this dye indicates mitochondrial membrane potential indepen-
dently of their mass which is important due to the fact that the
mitochondrial mass is increased in giant senescent cells. The ratio
of red/green mitochondria was calculated by flow cytometry,
confirming that dox-treated cells show an increase in the
proportion of depolarized mitochondria (Figure 4B, right panel).
Because depolarized mitochondria can produce more ROS, we
studied the level of H2O2 using a fluorescent probe, DCF-DA,
and flow cytometry, and we observed its substantial increase on
day 1 + 1 which was followed by a slight reduction on day 1 + 5
(Figure 4B, lower panel).
Figure 2. Perinuclear vesicles visualized by immunostaining of different nuclear proteins in untreated and dox-treated HCT 116 cells.
Lamin A/C (A, red), Aurora B (B, red), p21 (C, green; E, red), and p53 (D, green). Nuclei were stained with DAPI (blue) and actin with
phalloidin conjugated with TRITC (E, green). Cells are from day 1 + 5 (A-D) and day 1 + 3 (E). The cell gallery is presented. Each bar
represents 25 μm.
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was revealed during senescence of mesenchymal cells [32]. Indeed, we
already observed an increased level of this protein on day 1 + 2, which
persisted until the end of the experiment (Figure 4C).
As we documented an increased level of ROS in cells undergoing
senescence, we were interested whether scavenging them can change
the cell fate. Indeed, we observed a significant reduction of the level of
ROS upon Trolox treatment (Figure 5A). Moreover, in the
Trolox-treated population, there were fewer polyploid cells, but
these were observed only on day 1 + 1 (Figure 5B). However, this
treatment did not prevent the cells from undergoing senescence as it
was revealed by SA-β-Gal activity measured using flow cytometry
(Figure 5C). Interestingly, these cells had a substantially reduced
colony formation capability, indicating that there were no senescence
evaders and that ROS might be needed for the divisions of polyploid
cells (Figure 5D).
Senescence, But Not Polyploidization, of Doxorubicin-Treated
MCF7 Cells
We were interested whether other cells than HCT 116 can
undergo dox-induced senescence which would not be connected with
the polyploidization. Thus, we used the same protocol for the
induction of senescence in MCF7 cells. As can be seen in Figure 6,these cells became SA-β-Gal positive (Figure 6A) and showed an
increased level of p53, p-p53, and p21 (Figure 6B); however, their
ploidy did not increase (they are already paratriploid) (Figure 6C).
The clonogenicity assay displayed that their proliferation is stably
arrested (Figure 6D). Moreover, we did not observe under the
microscope the presence of small escapers (not shown). Thus, we can
conclude that not senescence per se but increased ploidy is responsible
for cell regrowth.
Different Expression of mTOR and Pim-1 in Dox-Treated
HCT 116 and MCF-7 Cells
Subsequently, we asked the question whether some signaling
molecules could be responsible for the different propensity of
HCT 116 and MCF-7 cells to undergo polyploidization upon
dox treatment. There are controversial data indicating the role of
the p16/Rb signaling pathway in cancer cell senescence as well as
in the escape from it (reviewed in [33]). However, our
experiments excluded the possibility that pRb could be the
possible factor responsible for the observed differences between
the two cell lines (not shown). This could be explained by the
fact that both types of cells lack the functional p16. Thus, we
focused our attention on two serine/treonine kinases, namely,
mTOR and Pim-1.
Figure 3. Nuclear protein staining (Ki-67 and p21) and SA-β-Gal activity in dox-treated HCT 116 cells. Cells were untreated or treated with
dox (day 1 + 7) as indicated. (A) Cells triple stained for Ki-67 (pink), SA-β-Gal (red), and F-actin (white). SA-β-Gal is also shown in the light
microscopy (upper right panel). (B) Cells triple stained for Ki-67 (green), p21 (red), and F-actin (white). Nuclei are blue (DAPI). Each bar
represents 25 μM.
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and metabolism [34]. In numerous cancer types, the mTOR signaling
pathway is activated by deregulation of its upstream factors, such as
Akt activation, and stimulates cellular mass growth which is coupled
with cell cycle progression. Furthermore, mTOR is associated with
the development of cell polyploidization [35]. Recent studies have
shown that mTOR inhibitors prevented the induction of polyploidy/
senescence in breast cancer cells [36].
Our results (Figure 7A) have shown different activity of this kinase
in dox-treated HCT 116 (increased) and MCF7 (not changed) cells,
suggesting that its activation is rather connected with polyploidization
(mass growth) than cell senescence.
The Pim-1 oncogene is the founding member of the Pim
serine-threonine kinase family involved in the development of various
tumors of hematological and epithelial origin [37]. It was demon-
strated that overexpression of Pim-1 in human prostate and breast
epithelial cells results in the gradual emergence of polyploid cells and
that polyploidy induced by Pim-1 can promote the development of
chromosomal abnormalities and tumorigenicity in human prostate
and mammary epithelial cells [38]. Recently, it has been documented
that Pim-1 is overexpressed during replicative and oncogene-induced
senescence of normal human fibroblasts [39]. Others have shown that
Pim-1 kinases prevent premature cardiac aging and are responsible for
maintaining a healthy pool of functional mitochondria leading to
efficient cellular energetics [40]. Our results show that MCF7 cells, incontrast to HCT116 cells, do not express Pim-1, which could explain
the lack of increase in ploidy in these cells (Figure 7B). Furthermore,
we observed a high basal level of Pim-1 in HCT 116 cells which
transiently dropped. Surprisingly, this reduction seems to be
associated with increased ploidy. These results indicate that indeed
Pim-1 or other family members could be responsible for the different
propensity of HCT 116 and MCF7 cells to undergo polyploidization
upon dox treatment. This issue requires further investigation.
Discussion
Senescence of cancer cells is considered as an outcome of radio/
chemotheraphy, and SA-β-Gal–positive cells were shown not only
in vitro but also in vivo in tumor sections after therapy [6]. However,
therapy-induced senescence seems not to be beneficial as it may lead
to cancer recurrence.
Genomic instability, including polyploidy, is a characteristic
feature of most cancers [41]. HCT 116 cells are not polyploid, but
they have a near diploid set of chromosomes (70% of cells have 45
chromosomes). However, the pulse treatment of HCT116 cells with
dox or curcumin leads to the formation of polyploid cells with the
DNA increase reaching as much as 32C [18,42].
Subsequently, we observed gradual depolyploidization without the
symptoms of cell death. The small cells outgrew the culture quite
rapidly. The colonies of small cells were usually visible in the vicinity
of giant cells.
Figure 4. ROS production during senescence of HCT 116 cells. (A and B) Mitochondrial parameters in HCT 116 cells undergoing
senescence. Visualization of mitochondria and mitochondrial mass was achieved using the MitoTracker Green FM and fluorescent
microscope or flow cytometry, respectively. Mitochondrial potential and ROS level were measured using flow cytometry as described in
Materials and Methods. The results are means from three independent experiments. Magnification is 600×. (C) β-Catenin in dox-treated
cells as revealed by Western blotting.
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polyploid cancer cells could divide by budding and produce,
presumably, cancer stem cells, thus paving the way for understanding
cancer cell repopulation after therapy [43]. Subsequently, Erenpreisa’s
group documented the presence of meiotic proteins during reversible
polyploidy arguing for reductional divisions of polyploid cells, which
can be followed by mitotic divisions of the descendants [44].
Recently, Zhang and colleagues documented that giant/polyploid but
SA-β-Gal–negative cells can divide by budding and bursting, givingrise to the generation of cancer stem cells [45]. Our results further
support the concept of amitotic division of polyploid cells. This type
of division can be favored by labile nuclear lamina, as we have
documented. We observed many perinuclear vesicles in giant cells.
However, we could not detect DNA in these vesicles. Similar results
were recently obtained in immortalized cells in which polyploidy and
senescence were induced by irradiation [12]. In addition, others have
shown vesicles in dox-treated HCT 116 cells containing DNA [13]. It
cannot be excluded that they just contain a lower, hardly detectable
Figure 5. Trolox (Tx) reduced ROS production, polyploidy, and colony formation but not SA-β-Gal activity in dox-treated HCT116 cells. (A,
left panel) Analysis of the level of ROS (DCF fluorescence) in untreated, dox-treated, and dox + Tx–treated cells on day 1 + 1.
Representative histogram of flow cytometric measurement. (Right panel) A compilation of the ROS level analysis from five independent
experiments. Statistical significance betweenuntreated anddox-treated cells (###P b .001) aswell as dox-treated anddox+Tx–treated cells
(*Pb .05)was estimated using theStudent’s t test. (B, left panel) Representative histogramsofDNAcontent analysis (day 1+1). (Right panel)
A compilation of the level of polyploidy in untreated, dox-treated, and dox + Tx–treated cells on indicated days (four independent
experiments). Statistical significance was analyzed using the Student’s t test. *** P b .001. (C, left panel) A representative histogram of
flow cytometric analysis of SA-β-Gal activity in untreated, dox-treated, and dox + Tx–treated cells on day 1 + 3. C12FDG is a SA-β-Gal
substrate. (D) A representative image of the colony formation assay of cells either untreated or treated with dox or dox + Tx (day 1 + 5).
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entities observed within the giant cells were also Ki67 positive. Thus,
no one can deny the existence of heterogeneity in the mode of
division of these genetically unstable cells. Although we believe that
polyploidy is followed by amitotic divisions of polyploid cells, no one
can also exclude other possibilities. We observed a lot ofmultinucleated cells with different DNA content suggesting that
they could have underwent aberrant mitoses. Although some
SA-β-Gal–positive cells are Ki-67 negative, the majority of giant
cells preserve the capacity to divide. Others have shown that
SA-β-Gal–positive cells simultaneously express Ki-67 and occasion-
ally divide. This “SWING” is dependent on p21 and telomerase
Figure 6.Markers of senescence of dox-treated MCF-7 cells. (A) SA-β-Gal–positive cells. Cells were untreated (day 0) or dox treated until
day 1 + 7. (B) Western blotting analysis of p53, p-p53, p21, and PARP-1. (C) DNA content measured using flow cytometer. Days of
treatment are indicated. (D) A representative image of the colony formation assay of cells either untreated or treated with dox (day 1 + 7).
Figure 7.mTOR and Pim-1 level in dox-treated HCT 116 and MCF7 cells. (A) Western blotting analysis of the mTOR substrates p70S6 and
4EBP1/2 and their phosphorylated forms. (B) Pim-1 level. K562 cells were used as a positive control for Pim-1 expression. GAPDH was
used as a loading control.
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Figure 8. Scheme outlining the role of polyploidy formation, ROS scavenging, as well as mTOR activity and Pim-1 level in reversed and
unreversed senescence of cancer cells. Cancer cells treated with anticancer agent undergo either senescence or polyploidization/
senescence. Polyploidization is associated with the increase of ROS level and the resuming of cell divisions, which can be avoided by
antioxidant treatment. Basal Pim-1 expression and mTOR activation seem to be indispensable for polyploidy formation.
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and OCT-4 could be expressed in the same cell. On the contrary,
others provided evidence that only escapers of drug-induced
senescence had a tumor stem cell–like phenotype [9,12]. Because,
in MCF7 cells, which do not increase polyploidization upon dox
treatment, we did not observe cells which were able to escape
senescence, we speculate that the formation of polyploidy is
indispensable for abnormal divisions and escaping senescence.
Interestingly, others have reported the evasion of progeny in
dox-treated MCF7 cells; however, the involvement of polyploidy
was not considered in that study [47]. The molecular mechanism
showing polyploidy formation is still awaiting elucidation.
Some explanation of this phenomenon can come from revealing
the role of ROS in senescent cells and in the evaders. Gosselin and
colleagues documented that oxidative stress induced epithelial cell
senescence and that these cells were able to divide by “budding-
mitosis” [48]. This is in favor of our results showing that doxorubicin
treatment generates ROS production and mitochondrial changes in
giant cells and scavenging ROS by Trolox protected from the
emergence of escapers. Similarly, Achuthan and colleagues docu-
mented that a senescent population of cancer cells had a high level of
ROS. Moreover, they occasionally generated stem-like cells with low
ROS [9].
It has been postulated, at least for replicative cell senescence, that
ROS production is necessary for the stability of growth arrest during
the establishment of the senescent phenotype [49]. On the contrary,
Blagosklonny postulated that the main drawing force for senescence is
mTOR, which induces hyperfunction including ROS production
[50]. We show that ROS scavenging did not protect from
dox-induced senescence, but the number of polyploid cells was
slightly and temporarily diminished after Trolox treatment. More-
over, Trolox protected from the emergence of small escapers, whichcould be the progeny of giant polyploid ones. However, we cannot
definitely exclude the role of ROS in cell senescence as we only
measured the level of ROS till day 1 + 3 and their increase might
occur at later time points when they might participate in establishing
the senescence phenotype. Accordingly, we speculate that the subtle
balance of the level of ROS can be responsible for their growth
arrest/stimulation capability.
We also decided to investigate whether the differences in the
expression of two kinases (mTOR and Pim-1) in these cells could be
responsible for their propensity to form polyploid cells. mTORmight
be connected with cell senescence by different mechanisms. One is the
so-called geroconversion, which is postulated by Blagosklonny [51],
and the second one is autophagy [52]. As the role of both processes in
cell senescence is rather controversial and unlikely to be helpful in
explaining the reversibility of cell senescence, our interpretation of the
different activity of mTOR in HCT 116 and MCF7 cells focused on
its possible role in polyploidy formation. Indeed, it seems that there is
an increased activity of this kinase only in polyploidizing HCT 116
cells. Our other candidate, Pim-1, looks very promising, although its
role in cell senescence seems to depend very much on the cell type.
Nonetheless, our feeling is that the issue of the role of Pim-1 in
polyploidy/senescence deserves further elucidation.
The main conclusion which emerges from our studies is that drug
treatment of cancer cells can lead to their senescence; however, the
cells which along with senescence undergo polyploidization are prone
to escape this process. ROS scavengers prevent polyploidy formation
and evasion of senescence. Thus, the increase of ploidy, not
senescence per se, favors emergence of the progeny. Cells which are
not immanently able to undergo polyploidization upon senescen-
ce-inducing conditions are protected from reversible senescence. The
high basal level of Pim-1 and increased activity of mTOR after cell
treatment seem to be indispensable for the association with
892 Polyploidy Formation in Cancer Cells Mosieniak et al. Neoplasia Vol. 17, No. 12, 2015senescence ploidy formation. This idea is outlined in the scheme
presented in Figure 8.
Our results might contribute to the development of anticancer
therapy through protection of senescence-induced polyploidization.
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